Insights from <i>in silico</i> exploration of major curcumin analogs targeting human dipeptidyl peptidase IV-Reference-Cited by-同舟云学术

Insights from in silico exploration of major curcumin analogs targeting human dipeptidyl peptidase IV

Published:2024-01-23 Issue: Volume: Page:1-14
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Roney Miah¹²^ORCID,Dubey Amit³⁴,Issahaku Abdul Rashid⁵,Uddin Md. Nazim⁶,Tufail Aisha⁴,Wilhelm Anke⁵,Zamri Normaiza Binti¹,Aluwi Mohd Fadhlizil Fasihi Mohd¹²

Affiliation:

1. Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al-Sultan Abdullah, Lebuhraya Tun Razak, Gambang, Kuantan, Pahang Darul Makmur, Malaysia

2. Bio Aromatic Research Centre, Universiti Malaysia Pahang Al-Sultan Abdullah, Lebuhraya Tun Razak, Gambang, Kuantan, Pahang Darul Makmur, Malaysia

3. Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India

4. Department of Computational Chemistry and Drug Discovery Division, Quanta Calculus, Greater Noida, Uttar Pradesh, India

5. Department of Chemistry, University of the Free State, Bloemfontein, South Africa

6. Institute of Food Science and Technology, Bangladesh Council of Scientific and Industrial Research, Dhaka, Bangladesh

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2024.2306197

Reference72 articles.

1. Discovery, synthesis and in combo studies of Schiff’s bases as promising dipeptidyl peptidase-IV inhibitors

2. Evaluation of antiviral activity of Carica papaya leaves against SARS-CoV-2 assisted by metabolomic profiling

3. Curcumin as a wound healing agent

4. A Molecular Modeling Investigation of the Therapeutic Potential of Marine Compounds as DPP-4 Inhibitors

5. Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches